Prophylaxis

Displaying 31 - 39 of 39

Researchers solve the expensive vaccine chiller issue

Researchers solve the expensive vaccine chiller issue
  Vaccines against killer diseases from polio to hepatitis are fragile and can easily be made useless if they get too hot or too cold. The problem is particularly acute in the developing countries where nearly one in five of the world’s population – 1.3bn people – live without access to electricity.
6th July 2016

E. coli-based transport capsule enables next-gen vaccines

E. coli-based transport capsule enables next-gen vaccines
Researchers experimenting with harmless strains of E. coli are working toward developing an E. coli-based transport capsule designed to help next-gen vaccines do a more efficient and effective job than today's immunisations. The research, described in a study published in the journal Science Advances, highlights the capsule's success in fighting pneumococcal disease, an infection that can result in pneumonia, sepsis, ear infections and meningitis.
5th July 2016

Programmable RNA vaccines could work against Ebola and influenza

Programmable RNA vaccines could work against Ebola and influenza
MIT engineers have developed a type of easily customisable vaccine that can be manufactured in one week, allowing it to be rapidly deployed in response to disease outbreaks. So far, they have designed vaccines against Ebola, H1N1 influenza, and Toxoplasma gondii (a relative of the parasite that causes malaria), which were 100% effective in tests in mice. The vaccine consists of strands of genetic material known as messenger RNA, which can be designed to code for any viral, bacterial, or parasitic protein.
5th July 2016


Vaginal ring could help prevent AIDS

Vaginal ring could help prevent AIDS
A vaginal ring that prevents the transmission of AIDS could help millions of women living under high contagion risk, especially in the poorest countries. The ring slowly releases an antiretroviral drug. The device has been presented by the International Partnership for Microbicides (IPM), a non-profit organisation. This silicone ring, that is placed in the vagina and must be replaced every four weeks, helps tackle the epidemic in the region where women aged 15 to 24 are twice more likely to contract HIV than men.
23rd May 2016

A total solution for smart healthcare

A total solution for smart healthcare
With rising populations and life expectancy around the world, countries are all facing the issue of ageing. More and more people are becoming focused on preventive healthcare for disease prevention.
25th April 2016

A stepping stone for the development of TB vaccine

A stepping stone for the development of TB vaccine
A team of scientists led by Oxford University have made a discovery that could improve the chances of developing an effective vaccine against Tuberculosis. The researchers have identified new biomarkers for TB which have shown for the first time why immunity from the widely used BCG vaccine is so variable. The biomarkers will also provide valuable clues to assess whether potential new vaccines could be effective.
12th April 2016

Reducing risk factors

Reducing risk factors
All Programmable FPGAs and SoCs give medical device manufacturers the flexibility needed to satisfy stringent regulatory requirements and manage the design process efficiently. Aaron Behman, Director, Corporate Strategy & Marketing, Embedded Vision, Xilinx explains
5th April 2016

Flu vaccine protects against multiple strains including H1N1

Flu vaccine protects against multiple strains including H1N1
  Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models. They published their findings recently in the Journal of Virology.
29th March 2016

Grass extract produces thinner and stronger condoms

Grass extract produces thinner and stronger condoms
Microscopic fibers produced from grasses enable the production of thinner and stronger condoms, when added to latex. If commercially viable, the discovery could bolster the struggling quest for more popular condoms, increasing usage vastly. The same process could also make possible latex gloves that are less tiring to wear - an important consideration for extended surgery. 
11th February 2016


Prophylaxis documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

PPMA Show 2017
26th September 2017
United Kingdom NEC, Birmingham
World’s top 50 innovators from the industries of the future
27th September 2017
United Kingdom London
New Scientist Live 2017
28th September 2017
United Kingdom Excel, London
Kiosk Summit 2017
28th September 2017
United Kingdom London
act! 2017
28th September 2017
Germany NHOW Berlin